In this context, we may hypothesize that calprotectin released by activated immune cells promotes TLR4 signaling with consequent production of TGFβ, which triggers fibroblast proliferation, leading to skin and pulmonary fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.